Merck Millipore’s Strat-M synthetic membrane shows benefits in study

Merck Millipore has announced the publication of a study showing the benefits its Strat-M synthetic membrane offers for in vitro transdermal diffusion studies.

Conducted at Josai University and published in the European Journal of Pharmaceutical Sciences, the research demonstrated that Strat-M can predict skin permeation of chemical compounds as effectively as human or animal skin.

A non-animal-based model that is predictive of diffusion in human skin for a wide range of compounds and formulations, Strat-M is optimised for testing active pharmaceutical ingredients, cosmetic actives, personal care products, pesticides and other chemicals.

The membrane provides highly consistent, reproducible diffusion data without the lot-to-lot variability that often occurs with biological models.

Dr Patrick Schneider, head of bioscience at Merck Millipore, said: "Published results supporting the membrane's application will increase awareness and accelerate adoption by the research community, facilitating in vitro testing of transdermal formulations."

Last month, the company launched its Magna ChIRP RNA Interactome Kits, for use in the analysis of chromatin-associated RNAs.